Skip to content
Home/Companies/Healthcare/PromoPharma
PromoPharma

PromoPharma

Healthcare·Italy·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns PromoPharma?

PromoPharma is currently owned by Aurora Growth Capital through Aurora Growth Capital (SICAV-RAIF) (2018 vintage), since 2022.

Hand-verified · updated 2026-07-21

Aurora Growth Capital
Investor
Aurora Growth Capital
Aurora Growth Capital (SICAV-RAIF) · 2018 · Growth

Key facts

HQItaly
SectorHealthcare
StatusActive
Websitewww.promopharma.it

More from Aurora Growth Capital (SICAV-RAIF)

Other portfolio companies in the same fund.

Eurmoda
Eurmoda
Active
ConsumerItaly· 2025
Genetic
Active
PharmaItaly· 2025
Ca'Zampa
Ca'Zampa
Active
HealthcareItaly· 2024
Finlogic
Finlogic
Active
IT ServicesItaly· 2023
Comet
Comet
Active
IndustrialsItaly· 2021
Exacer
Exacer
Exited 2025
MobilityItaly· 2021
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track PromoPharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy PromoPharma?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on PromoPharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue